Combination therapy comprising a TOR kinase inhibitor and N-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide for treating cancer

• 收藏
• 分享

专利权人:

LLC;Signal Pharmaceuticals

发明人:

Hege, Kristen Mae,Chopra, Rajesh

申请号：

AU2014254057

公开号：

AU2014254057A1

申请日:

2014.04.16

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount of

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/